Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CREB3L4 |
| Upstream (Parents) |
|---|
| (<<) CHODL → CREB3L4 |
| (<<) CMTM7 → CREB3L4 |
| (<<) DUSP4 → CREB3L4 |
| (<<) MLPH → CREB3L4 |
| (<<) MSN → CREB3L4 |
| (<<) SPDEF → CREB3L4 |
| (<<) TRIB3 → CREB3L4 |
| (<<) UGDH → CREB3L4 |
| Downstream (Children) |
|---|
| CREB3L4 → ALOX15B (>>) |
| CREB3L4 → ANKRD27 (>>) |
| CREB3L4 → ARSD (>>) |
| CREB3L4 → ATP2C2 (>>) |
| CREB3L4 → CBS (>>) |
| CREB3L4 → CCDC88A (>>) |
| CREB3L4 → CDC42EP2 (>>) |
| CREB3L4 → CHI3L1 (>>) |
| CREB3L4 → CHST2 (>>) |
| CREB3L4 → CISH (>>) |
| CREB3L4 → CREB3L1 (>>) |
| CREB3L4 → DUSP6 (>>) |
| CREB3L4 → EPN3 (>>) |
| CREB3L4 → ERBB2 (>>) |
| CREB3L4 → ERBB3 (>>) |
| CREB3L4 → FA2H (>>) |
| CREB3L4 → FZD4 (>>) |
| CREB3L4 → GLS (>>) |
| CREB3L4 → GRB7 (>>) |
| CREB3L4 → ITGB8 (>>) |
| CREB3L4 → KRT5 (>>) |
| CREB3L4 → LEMD1 (>>) |
| CREB3L4 → LPIN1 (>>) |
| CREB3L4 → MAPK13 (>>) |
| CREB3L4 → MIA3 (>>) |
| CREB3L4 → MLXIPL (>>) |
| CREB3L4 → MMP7 (>>) |
| CREB3L4 → NRAS (>>) |
| CREB3L4 → PRKX (>>) |
| CREB3L4 → PSAT1 (>>) |
| CREB3L4 → PTPLA (>>) |
| CREB3L4 → RARA (>>) |
| CREB3L4 → RDH16 (>>) |
| CREB3L4 → TFF1 (>>) |
| CREB3L4 → THRA (>>) |
| CREB3L4 → TM4SF1 (>>) |
| CREB3L4 → TMEM158 (>>) |
| CREB3L4 → TMEM45B (>>) |
| CREB3L4 → TWIST2 (>>) |
| CREB3L4 → VPS37B (>>) |
| CREB3L4 → VTCN1 (>>) |
